Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 551 clinical trials
Hallucinations in Parkinson's Disease

Investigation on how robotically mediated sensorimotor stimulation induces and triggers presence hallucinations in different clinical groups of parkinsonian patients, and in aged-matched controls

  • 0 views
  • 25 Jan, 2021
  • 6 locations
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders

To explore the whole-brain anatomical and functional abnormalities in drug-naive patients with schizophrenia ,drug-naive patients with BD, drug-naive patients with MDD and healthy controls by using a combination of cross-sectional and longitudinal study designs, including a longitudinal study with 8 weeks of drugs treatment. And explore whether there are shared …

  • 0 views
  • 25 Jan, 2021
  • 1 location
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs

Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC

  • 0 views
  • 27 Jan, 2021
  • 3 locations
Artificial Intelligence to Measure Adherence to Oral Medication

The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.

  • 0 views
  • 27 Jan, 2021
  • 2 locations
Fluoxetine vs Aripiprazole Comparative Trial (FACT)

We are conducting a randomized, 24-week, double-blind study, comparing fluoxetine with aripiprazole in 48 patients with attenuated positive symptoms at a level of at least moderate severity.

  • 1 views
  • 24 Feb, 2021
  • 1 location
Evaluation of the Treatment Approach ROBIN

The prevention of schizophrenia and other psychotic disorders has led researchers to focus on early identification of individuals at Clinical High Risk (CHR) for psychosis and to treat the at

  • 0 views
  • 22 Jan, 2021
Ball Blankets on Insomnia in Depression in Outpatient Clinics

The objective of the study is to examine the efficacy of Protac Ball BlanketsTM (PBB) and specifically if the PBB will extend the total sleep time of patients with insomnia due to depression in two psychiatric outpatient clinics at Aarhus University Hospital and Odense University Hospital. Furthermore, it will be …

  • 3 views
  • 23 Jan, 2021
  • 2 locations
tDCS Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk Youth

Negative symptoms, which include the loss of motivation, social withdrawal and reduced emotional expression are prominent in youth at clinical high risk (CHR) for psychosis. These negative

  • 0 views
  • 24 Jan, 2021
  • 1 location
Social Skills Training in Refractory Schizophrenia

Objective Primary: To evaluate the efficacy of social skills training in reducing negative symptoms in patients with refractory schizophrenia, in comparison with control (befriending group). Secondary: To evaluate changes in social functioning. To evaluate the effect of SST in other dimensions of psychopathology: positive symptoms, depression and general psychopathology. To …

  • 0 views
  • 07 Nov, 2020
  • 1 location
TMS for Symptom Reduction in Schizophrenia

Neuroimaging studies suggest that aberrant activities at specific brain regions such as sensory areas and language-related areas are related to psychosis symptoms including auditory and visual

  • 1 views
  • 23 Jan, 2021
  • 1 location